Question

In: Economics

You are CEO of a new firm, DUNSMED, Inc. which has invented a successful Covid-19 vaccine....

You are CEO of a new firm, DUNSMED, Inc. which has invented a successful Covid-19 vaccine. The US government has given you an exclusive patent on the drug for 10 years. The government, in exchange for granting this exclusive patent, wants all 100,000 doses manufactured for the first year. As CEO of the company, you are in charge of pricing for the drug and the Marginal Cost is equal to the Marginal Revenue at a price of $2,000 per dose. Demand is extremely high for the drug as your firm is the only company that has invented a Covid-19 vaccine and the Marginal Cost is equal Demand at the price of $10,000 per dose but you can only fill the government's order of 100,000 doses. Please answer the following questions given this information.

a. For the first year, what type of market environment is your firm operating in? What characteristics lead you to believe that and why? Explain clearly and thoroughly (5 sentences minimum are required).

b. What is the minimum price your firm should charge for the drug per dose? Why and how did you come up with the pricing? Explain clearly and thoroughly (5 sentences minimum are required).

c. After the patent expires and the drug is no longer in strong demand, assume 10 other companies all create generic versions of the same vaccine. Your competitors are all charging $11 per dose. Marginal Revenue equals Marginal Cost at $11 per dose. What type of market environment is your firm operating in and why? What price should you charge now? Explain clearly and thoroughly (5 sentences minimum are required).

d. Given that 10 other companies are already creating the same vaccine. Would your firm earn an economic profit assuming you priced the vaccine at the same level as your competitors? Additionally, what would happen if your firm would charge more than your competitors? What would happen if you charge less than your competitors? Explain clearly and thoroughly (5 sentences minimum are required).

Solutions

Expert Solution

a. As can be seen from the above sentences, we can say that for the first year the firm is operating in a market structure called monopoly. This is because the characteristics of this firm is matching with that of monopoly, like the firm is the only (single) producer of the vaccine in the market, it has control over the price of the product i.e. market power, there are high barriers to entry as other firm has not developed a vaccine and can't use this formulae because of patent. So these all are the basic characteristics of a monopoly market.

b. The firm can charge a minimum price of $2,000, because at this price MR=MC and hence the firm can easily recover its cost. But since this is a monopoly market here the price is set at the point on demand or AR curve corresponding to the point of intersection of MC and MR curve. So the equilibrium price will be $10,000.

c. After the patent expires and the drug is no longer in strong demand, assume 10 other companies all create generic versions of the same vaccine. Your competitors are all charging $11 per dose. Marginal Revenue equals Marginal Cost at $11 per dose. This market structure is similar to perfect competition because there are now many firms and all are selling similar product which are substitutes for one another and the equilibrium is also taking place at MR=MC=$11, which is also the price charged by all firms. Hence all firms are earning normal profit and I must also charge the same price of $11 now.

d. Given that 10 other firms are already producing the vaccine, my firm will not earn an economic profit if the price is same for all the firms but it will earn only a normal price. If I charge a higher price than my competitors my sale will go down as people will buy other vaccines and I may incurr loss. If I charge a lower price than I will earn a higher revenue due to increase in demand but still I will come up with loss because I can't recover my cost.


Related Solutions

A Mexican laboratory developed a new vaccine against COVID-19, which should be stored at an average...
A Mexican laboratory developed a new vaccine against COVID-19, which should be stored at an average daily temperature of 8 degrees, with a standard deviation of 3 degrees. If the distribution of daily temperatures is approximately normal. What is the probability that: A) On a given day the temperature would have been between 6 and 9 degrees B) The first day a temperature of at most 7.1 degrees is reached is before 6 days
Suppose that the pharmaceutical company Abstergo Industries successfully develops the first successful vaccine for COVID-19. If...
Suppose that the pharmaceutical company Abstergo Industries successfully develops the first successful vaccine for COVID-19. If the United States government implements regulation that requires Abstergo to sell vaccine doses at marginal cost (rather than charging a higher price as it otherwise would), this will reduce Abstergo’s profit from the vaccine by $12 billion and increase the well-being of vaccine consumers by $17 billion, creating an overall efficiency gain of $5 billion. Explain why this regulation would not result in a...
1. COVID-19 disease has spread globally, and there is demand for vaccine development. If you are...
1. COVID-19 disease has spread globally, and there is demand for vaccine development. If you are supported by the funding and experts, how will you design a nucleic acid/protein based vaccine or treatment for the disease? 2. Describe and differentiate the conjugation, transformation, and transduction processes that allow genes to be horizontally transferred.
A scientist has discovered the vaccine formula to the COVID-19 and received a patent for it...
A scientist has discovered the vaccine formula to the COVID-19 and received a patent for it (a legal monopoly). The scientist has signed a contract with a pharmaceutical company that will produce and sell the vaccine on the market. The monopoly pharmaceutical supplier faces an inverse demand curve P = 20 - (1/80)Q with marginal revenue MR = 20 – (1/40)Q, where Q is the output of vaccine in units and P is the market price per unit. The company...
How will a vaccine against the COVID-19 virus be developed?
How will a vaccine against the COVID-19 virus be developed?
How do you think covid-19 will affect the anti-vaccine movement?
How do you think covid-19 will affect the anti-vaccine movement?
Covid-19 infection has become a reality to live with, and even if a vaccine becomes available...
Covid-19 infection has become a reality to live with, and even if a vaccine becomes available it may not prevent the spread of the infection. This scenario has given rise to new norms for regular life and work/study. Please provide your views on: a) What are the new norms, and how will these affect daily life styles and learning/work practices?
Do you anticipate a similar outcome if a biopharmaceutical were to discover a vaccine for Covid-19?
Do you anticipate a similar outcome if a biopharmaceutical were to discover a vaccine for Covid-19?
COVID-19 vaccine was tested in a randomised controlled trial in which 400,000 adults selected from the...
COVID-19 vaccine was tested in a randomised controlled trial in which 400,000 adults selected from the population were divided into two similar groups. Adults in one group were given the vaccine while those in the other group were given a placebo. At a later date the number of adults contracting COVID-19 in each group were determined. In the vaccine group, there were 56 cases of COVID-19 out of 200,000 adults while in the placebo group, there were 142 cases of...
COVID-19 vaccine was tested in a randomised controlled trial in which 400,000 adults selected from the...
COVID-19 vaccine was tested in a randomised controlled trial in which 400,000 adults selected from the population were divided into two similar groups. Adults in one group were given the vaccine while those in the other group were given a placebo. At a later date the number of adults contracting COVID-19 in each group were determined. In the vaccine group, there were 56 cases of COVID-19 out of 200,000 adults while in the placebo group, there were 142 cases of...
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT